Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapies; An Observational Prospective Study

NCT06031233 is registered in ClinicalTrials.gov with Isala as lead sponsor.

NCT NCT06031233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06031233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapies; An Observational Prospective Study
Lead sponsor
Isala
Phase
Phase 4
Overall status
Recruiting
Start date
September 1, 2023
Completion date
December 31, 2028
Enrollment
776 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infusion reaction, oncology